Search Results
141 items found for "Bryan L. Roth"
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
single-domain antibody fragments from camelids, have become indispensable tools for interrogating GPCRs both technologies to discover nanobodies with tailored specificities may expand the impact of these tools for both
- The Adhesion GPCR VLGR1/ADGRV1 Regulates the Ca2+ Homeostasis at Mitochondria-Associated ER Membrane
proteomics revealed that in the interactome of VLGR1, molecules are enriched that are associated with both mitochondria, as well as mitochondria-associated ER membranes (MAMs), a compartment at the contact sites of both
- Case Report of a Juvenile Patient with Autism Spectrum Disorder with a Novel Combination of Copy...
Pseudogenes "We report the finding of two copy number variants (CNVs) in a 12-year-old boy presenting both Using array-based comparative genomic hybridization (array-CGH), we identified two CNVs, both triplex
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
Currently, the exact function of the C5aR2 is actively debated in the context of C5aR1, even though both to be context-dependent compared to the C5aR1, which has received enormous attention for its role in both
- Delineation of GPR15 receptor-mediated Gα protein signaling profile in recombinant mammalian cell
The results show that the GPR15 receptor preferentially couples to Gi/o rather than other pathways in both The potencies of both peptides toward each Gi/o subtype have been determined.
- Canonical chemokine receptors as scavenging “decoys”
CCR2 is an example of a dual-function receptor that directly regulates both cell migration and scavenging established for other chemokine scavenger receptors that where shown to couple to GRKs, β-arrestins, or both
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
YM-254890 (YM) can inhibit signaling by both GPCR-activated wild type αq and GPCR-independent αqQ209L Additionally, pull-down experiments demonstrated that YM promotes similar conformational changes in both
- Residency time of agonists does not affect the stability of GPCR-arrestin complexes
The interaction of arrestins with GPCRs requires both agonist activation and receptor phosphorylation
- Targeting the M1 muscarinic receptor in neurodegenerative disease
Heptares, recently presented at the Keystone Symposia GPCR Conference, a summary of work performed both
- Coordinated transcriptomics and peptidomics of central nervous system identify neuropeptides and ...
central nervous system identify neuropeptides and their G protein-coupled receptors in the oriental fruit moth Grapholita molesta The oriental fruit moth Grapholita molesta is a cosmopolitan pest of orchard, which
- Cell Surface Calcium-Sensing Receptor Heterodimers: Mutant Gene Dosage Affects Ca 2+ Sensing but...
When the same mutation was present in both VFT domains of receptor dimers, analogous to homozygous neonatal there was no functional difference between heterodimers in which the mutation was present in one or both
- AELIS PHARMA launches their IPO for €25 million
Thank you to our shareholders, both historical and new, for their trust.
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
canonical G protein signaling, shedding light on molecular mechanisms with significant implications for both These findings have broad implications for understanding cellular signaling in both normal physiology
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
inverse agonists also exhibit varying degrees of negative intrinsic efficacy, leading to the presence of both designed for this primary binding site, there are significant challenges in creating ligands that are both On the other hand, selectivity could be achieved by merging both orthosteric and allosteric pharmacophores
- Neurotransmitters: Potential Targets in Glioblastoma
novel discoveries have underlined the regulatory roles of neurotransmitters in the microenvironment both
- Dr. Tim De Groof - Dr. GPCR Podcast
It’s not often when you get the best of both worlds - nano-bodies and #GPCRs.
- Chemokine receptor-targeted drug discovery: progress and challenges
partially restored to the cell surface and partially targeted to lysosomes (Zimmermann, Conkright, and Rothenberg Furthermore, both chemokines and receptors can homo- and hetero-oligomerize, impacting receptor/ligand-binding which can only interact with the extracellular domain of the receptor ((Zimmermann, Conkright, and Rothenberg
- G protein-coupled receptor kinase type 2 and β-arrestin2: Key players in immune cell functions...
scaffolding protein β-arrestin2 are key integrated signaling nodes in various biological processes, and both
- The sixth transmembrane region of a pheromone G-protein coupled receptor, Map3, is implicated in ...
Although such pheromone/receptor systems are likely to function in both mate choice and prezygotic isolation with the respective domains in SoMam2 and SoMap3, which revealed differences between the receptors both
- The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells
CB1 receptor mRNA and protein has been recognized within myotubes and tissues of skeletal muscle from both This can be deduced from the qRT-PCR assays; triggering CB1 receptors amplifies both NR4A1 and NR4A3
- Crinetics Presents Clinical And Research Results At ENDO 2022
Crinetics recently reported that administration of CRN04894 reduced both serum cortisol levels and 24
- G protein-coupled receptor 21 in macrophages: An in vitro study
migration was detected by the Boyden chamber migration assay, performed on macrophages derived from both
- Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
commercial leader with more than three decades of experience leading sales and marketing operations for both
- Chemerin Forms: Their Generation and Activity
Methods of identifying and determining the levels of different chemerin forms in both mass and activity
- Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
with functional data, the structures reveal the key factors that govern the recognition of CX3CL1 by both
- Dopamine activates astrocytes in prefrontal cortex via α1-adrenergic receptors
signals in PFC astrocytes are time locked to dopamine release and are mediated by α1-adrenergic receptors both
- SLAS2022 International Conference and Exhibition
We are closely monitoring any regulation changes from both Boston and Massachusetts with regard to in-person
- Ode to GPCRs
prize awarded for work relevant to GPCR-mediated signaling was the 2012 Nobel Prize in Chemistry to Brian Brian K.